1. Home
  2. ENZ vs CIF Comparison

ENZ vs CIF Comparison

Compare ENZ & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • CIF
  • Stock Information
  • Founded
  • ENZ 1976
  • CIF 1988
  • Country
  • ENZ United States
  • CIF United States
  • Employees
  • ENZ N/A
  • CIF N/A
  • Industry
  • ENZ Medical Specialities
  • CIF Trusts Except Educational Religious and Charitable
  • Sector
  • ENZ Health Care
  • CIF Finance
  • Exchange
  • ENZ Nasdaq
  • CIF Nasdaq
  • Market Cap
  • ENZ 34.2M
  • CIF 31.5M
  • IPO Year
  • ENZ N/A
  • CIF N/A
  • Fundamental
  • Price
  • ENZ $0.56
  • CIF $1.74
  • Analyst Decision
  • ENZ
  • CIF
  • Analyst Count
  • ENZ 0
  • CIF 0
  • Target Price
  • ENZ N/A
  • CIF N/A
  • AVG Volume (30 Days)
  • ENZ 125.9K
  • CIF 43.9K
  • Earning Date
  • ENZ 03-12-2025
  • CIF 01-01-0001
  • Dividend Yield
  • ENZ N/A
  • CIF 10.11%
  • EPS Growth
  • ENZ N/A
  • CIF N/A
  • EPS
  • ENZ N/A
  • CIF N/A
  • Revenue
  • ENZ $30,314,000.00
  • CIF N/A
  • Revenue This Year
  • ENZ N/A
  • CIF N/A
  • Revenue Next Year
  • ENZ N/A
  • CIF N/A
  • P/E Ratio
  • ENZ N/A
  • CIF N/A
  • Revenue Growth
  • ENZ N/A
  • CIF N/A
  • 52 Week Low
  • ENZ $0.54
  • CIF $1.47
  • 52 Week High
  • ENZ $1.40
  • CIF $1.77
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 28.08
  • CIF 51.29
  • Support Level
  • ENZ $0.56
  • CIF $1.72
  • Resistance Level
  • ENZ $0.69
  • CIF $1.76
  • Average True Range (ATR)
  • ENZ 0.03
  • CIF 0.02
  • MACD
  • ENZ 0.00
  • CIF 0.00
  • Stochastic Oscillator
  • ENZ 11.54
  • CIF 62.50

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

Share on Social Networks: